Pneumococcal conjugate second or third-dose vaccines (PCVc) in Morocco
Morocco: Pneumococcal conjugate second or third-dose vaccines (PCVc) was 77.0% in 2025. ◆ Volatile
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Morocco, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for pneumococcal conjugate second or third-dose vaccines (pcvc) in Morocco is 77.0%, measured in 2025.
Compared with earlier readings it is down 18.9% over ten years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) in Morocco peaked at 99.0% in 2017 and was at its lowest, 0.0%, in 2008.
Morocco ranks 124th of 194 countries on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Morocco, year by year
| Year | Value | Change |
|---|---|---|
| 2008 | 0.0% | — |
| 2009 | 0.0% | — |
| 2010 | 1.0% | — |
| 2011 | 23.0% | +2200.0% |
| 2012 | 72.0% | +213.0% |
| 2013 | 80.0% | +11.1% |
| 2014 | 90.0% | +12.5% |
| 2015 | 95.0% | +5.6% |
| 2016 | 98.0% | +3.2% |
| 2017 | 99.0% | +1.0% |
| 2018 | 99.0% | +0.0% |
| 2019 | 98.0% | -1.0% |
| 2020 | 98.0% | +0.0% |
| 2021 | 98.0% | +0.0% |
| 2022 | 98.0% | +0.0% |
| 2023 | 88.0% | -10.2% |
| 2024 | 77.0% | -12.5% |
| 2025 | 77.0% | +0.0% |
Morocco compared with similar countries
- Morocco's 77.0% is below the median for lower middle income countries, which is 84.0%, 92% of the median. (47 countries reporting)
- Morocco's 77.0% is below the median for Middle East, North Africa, Afghanistan & Pakistan, which is 91.0%, 85% of the median. (23 countries reporting)
Biggest year-on-year movements
Years where Pneumococcal conjugate second or third-dose vaccines (PCVc) in Morocco changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2011 | +2200.0% | 1.0% | 23.0% |
| 2012 | +213.0% | 23.0% | 72.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 2 |
| 2010s | 75.5% | 1.0% | 99.0% | 10 |
| 2020s | 89.3% | 77.0% | 98.0% | 6 |
Countries ranked near Morocco
More health data for Morocco
- Un projection of annual infant deaths, annual growth rate -1.91 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.6655 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,240 deaths per 1,000 people (2090)
- Number of infants who die before age 1 925 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 3 (2018)
- Population ages 00-04, female, annual growth rate -1.13 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0396 units per person (2025)
- Population ages 00-04, male, annual growth rate -1.1 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) in Morocco?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) in Morocco was 77.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Morocco?
- The highest recorded value was 99.0% in 2017.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Morocco?
- The lowest recorded value was 0.0% in 2008.
- How does Morocco rank for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Morocco ranks 124th out of 194 countries with data for 2025.
- Is pneumococcal conjugate second or third-dose vaccines (pcvc) rising or falling in Morocco?
- Over the last ten years it is down 18.9%. The long-run trend across the full record is volatile.
- Where does this Morocco data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).